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Cell cycle progression through mitosis and meiosis involves regulation by serine or threonine kinases from aurora family.  
 Human aurora kinase b (AURKB) is a protein mainly involved in the proper segregation of  chromosomes during mitosis as well as meiosis. 
Over expression of AURKB leads to the unequal distribution of genetic information creating a aneuploid cells, a hallmark of cancer. and this heads to genetic instability is linked on primary non-
small cell lung carcinoma.  
Inhibition of AURKB  results inhibition of cytokinesis (or anticytokinesis), hence is an attractive anticancer strategy.  
In silico work was carried out to identify novel potent inhibitors towards human AURKB. 
Figure 1: Ramachandran plot for modeled Human AURKB 
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Figure 3: Graphical representation of XP 
Gscores.  
 
Analysis of the  Aurkb 3D model had revealed that ALA 157 an essential amino 
acid for AURKB activity is directly getting blocked  by lead 1 by forming hydro-
gen bond and good van der wall interactions.  
 Thus it would be highly effective as a novel inhibitor towards of human AURKB 
protein for treatment of metastasis.  
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Figure 4: Nine lead molecules and Lead1- AURKB docking complex. The docking 
complex revealed that two amino acid residues ASP 218 (two Hydrogen bonds) and 
ALA 157 of active sites were directly involved in formation of hydrogen bond net-
work. The active site residues detected from crystal structure also interacted with 
lead1 through good van der Waal contacts. 
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Figure 2: Modeled structure of AURKB with PDB 
ligand deciphering active site residues visualized 
through PyMol 
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